GlassScriptPhysician profile
Sara M Ebel
NPI 1750693289
$21,637.44
in general payments reported to CMS, 2019-2025
44 companies · $5,353 in 2025
The $5,353 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,745 · 2022: $2,422 · 2023: $2,238 · 2024: $8,880 · 2025: $5,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $4,438 · Travel and Lodging: $1,013 · Education: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,565.91 |
| Consulting Fee | $4,437.50 |
| Travel and Lodging | $1,012.56 |
| Education | $454.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $5,855.40 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $2,626.01 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,267.81 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,957.32 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Grifols USA, LLC | $1,064.43 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Takeda Pharmaceuticals U.S.A., INC. | $921.92 | 2021-2025 | Glassia, Hyqvia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $884.02 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Jazz Pharmaceuticals INC. | $766.74 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $667.89 | 2021-2025 | Dupixent |
| Insmed, INC. | $557.30 | 2021-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $539.62 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $408.66 | 2021-2024 | Tyvaso, Remodulin, Orenitram |
| Mallinckrodt Hospital Products INC. | $405.05 | 2022-2025 | Acthar |
| Viatris Specialty LLC | $340.30 | 2025 | Yupelri |
| Amgen INC. | $330.28 | 2022-2025 | Tezspire, Tavneos |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $322.26 | 2023-2025 | Winrevair, Zerbaxa |
| Baxter Healthcare | $201.59 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Abpm 6100 Blood Pressure Monitor |
| Johnson & Johnson Health Care Systems INC. | $153.06 | 2022-2024 | Opsumit, Uptravi |
| Verona Pharma, INC. | $140.66 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $131.71 | 2024 | Inspire |
| Pfizer INC. | $119.38 | 2022-2025 | |
| Philips North America LLC | $114.71 | 2021-2022 | |
| Vifor Pharma, INC. | $110.89 | 2024-2025 | Zemaira, Veltassa |
| Ethicon INC. | $107.45 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $76.27 | 2024-2025 | Lumryz |
| Advanced Respiratory, INC | $74.45 | 2021 | |
| Ani Pharmaceuticals, INC. | $66.48 | 2025 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $57.48 | 2025 | |
| Electromed, INC. | $48.93 | 2021-2024 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $37.18 | 2022 | |
| Abbott Laboratories | $36.99 | 2023-2025 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $29.19 | 2022-2023 | |
| Axsome Therapeutics, INC. | $25.31 | 2024 | Sunosi |
| Harmony Biosciences LLC | $24.92 | 2024 | |
| Irhythm Technologies, INC. | $21.43 | 2024 | Zio Monitor, Zio Xt Patch |
| Intuitive Surgical, INC. | $21.07 | 2024 | |
| Daiichi Sankyo INC. | $20.35 | 2024 | Enhertu |
| Genentech USA, INC. | $19.33 | 2022 | |
| Abbvie INC. | $16.54 | 2025 | |
| Phadia US INC. | $15.94 | 2024 | Immunocap |
| Paratek Pharmaceuticals, INC. | $13.94 | 2021 | |
| Csl Behring | $13.32 | 2021 | |
| Inogen, INC. | $12.71 | 2024 | |
| Janssen Pharmaceuticals, INC | $11.15 | 2024 | Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Ebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.